TABLE 3.
Covariate | β value | Standard error | p value |
---|---|---|---|
Log CYP3A4 protein content (pmol/mg protein) | |||
CYP3A4*1G/*1G diplotype | 0.12 | 0.09 | 0.18 |
log POR protein content | 1.06 | 0.13 | 5.0 × 10−14 |
100*AKR1D1 mRNA content | 0.30 | 0.97 | 2.5 × 10−3 |
UW sample collection | 0.04 | 0.06 | 0.52 |
100*Age by year | 0.34 | 0.13 | 0.01 |
Male | −0.06 | 0.06 | 0.10 |
CYP3A4*22 present | −0.21 | 0.09 | 0.03 |
Log CYP3A4 activity (pmol/mg protein/min) | |||
CYP3A4*1G/*1G diplotype | 0.18 | 0.11 | 0.12 |
Log POR protein content | 1.33 | 0.16 | 1.1 × 10−14 |
100*AKR1D1 mRNA content | 0.27 | 0.12 | 2.3 × 10−2 |
UW sample collection | 0.30 | 0.08 | 3.7 × 10−4 |
100*Age by year | 0.51 | 0.16 | 1.9 × 10−3 |
Abbreviations: POR, cytochrome P450 oxidoreductase; AKR1D1, aldo‐keto reductase 1D1; UW, University of Washington.